Westlin, III; William Frederick

Patent Applications and Registrations

Patent applications and USPTO patent grants for Westlin, III; William Frederick.The latest application filed is for "heteroaryl compounds and uses thereof".

Company Profile

4.17.15

Westlin, III; William Frederick - Boxborough MA
Westlin, III; William Frederick - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 11,351,168 - Singh , et al. June 7, 2	2022-06-07
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 10,828,300 - Singh , et al. November 10, 2	2020-11-10
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,596,172 - Singh , et al.	2020-03-24
Heteroaryl Compounds And Uses Thereof App 20190192512 - Singh; Juswinder ; et al.	2019-06-27
Heteroaryl Compounds And Uses Thereof App 20190117650 - Singh; Juswinder ; et al.	2019-04-25
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,010,548 - Singh , et al. July 3, 2	2018-07-03
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,987,276 - Singh , et al. June 5, 2	2018-06-05
Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20170173011 - Westlin, III; William Frederick ; et al.	2017-06-22
Heteroaryl Compounds And Uses Thereof App 20170100397 - Singh; Juswinder ; et al.	2017-04-13
Besylate salt of a BTK inhibitor Grant 9,604,936 - Witowski , et al. March 28, 2	2017-03-28
Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20160287588 - Witowski; Steven Richard ; et al.	2016-10-06
2,4-disubstituted pyrimidines as kinase inhibitors Grant 9,409,921 - Singh , et al. August 9, 2	2016-08-09
Methods of treating a Bruton's Tyrosine Kinase disease or disorder Grant 9,364,476 - Witowski , et al. June 14, 2	2016-06-14
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,296,737 - Singh , et al. March 29, 2	2016-03-29
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,212,181 - Singh , et al. December 15, 2	2015-12-15
Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20150216865 - Westlin, III; William Frederick ; et al.	2015-08-06
Heteroaryl Compounds And Uses Thereof App 20140213574 - Singh; Juswinder ; et al.	2014-07-31
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,710,222 - Singh , et al. April 29, 2	2014-04-29
Besylate Salt Of A Btk Inhibitor App 20140057929 - Witowski; Steven Richard ; et al.	2014-02-27
2,4-diaminopyrimidines useful as kinase inhibitors Grant 8,609,679 - Singh , et al. December 17, 2	2013-12-17
Besylate salt of a BTK inhibitor Grant 8,563,568 - Witowski , et al. October 22, 2	2013-10-22
Heteroaryl Compounds And Uses Thereof App 20130165462 - Singh; Juswinder ; et al.	2013-06-27
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,450,335 - Singh , et al. May 28, 2	2013-05-28
Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20130109709 - Witowski; Steven Richard ; et al.	2013-05-02
Heteroaryl Compounds And Uses Thereof App 20130072469 - Singh; Juswinder ; et al.	2013-03-21
Heteroaryl Compounds And Uses Thereof App 20130065899 - Singh; Juswinder ; et al.	2013-03-14
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,338,439 - Singh , et al. December 25, 2	2012-12-25
Besylate Salt Of A Btk Inhibitor App 20120077832 - Witowski; Steven Richard ; et al.	2012-03-29
Heteroaryl Compounds And Uses Thereof App 20100249092 - Singh; Juswinder ; et al.	2010-09-30
Heteroaryl Compounds and Uses Thereof App 20100029610 - Singh; Juswinder ; et al.	2010-02-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.